Travere Therapeutics, Inc. · NASDAQ:TVTX

Macquarie Group LTD reported a 5.41% stake in Travere Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 15, 2025

Macquarie Group LTD reported a 5.41% stake in Travere Therapeutics, Inc., 4,797,314 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).

Stake
5.41%
Shares
4,797,314
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Macquarie Group Limited5.41%4,797,314
Macquarie Management Holdings Inc5.41%4,797,314
Macquarie Investment Management Business Trust5.41%4,797,314

Source

View original at SEC

Related